Restoration of human dystrophin following transplantation of exonskipping-engineered DMD patient stem cells into dystrophic mice, Cell Stem Cell, vol.1, pp.646-57, 2007. ,
Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in mdx/SCID mice, Tissue Eng Part A, vol.18, pp.232-273, 2012. ,
Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development, Nat Cell Biol, vol.12, pp.257-66, 2010. ,
In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study, Mol Ther J Am Soc Gene Ther, vol.17, pp.1771-1779, 2009. ,
Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse, J Exp Med, vol.201, pp.1397-405, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00304039
Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts, Science, vol.301, pp.487-92, 2003. ,
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs, Nature, vol.444, pp.574-583, 2006. ,
Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin, Cell Transplant, vol.21, pp.1407-1424, 2012. ,
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy, EMBO Mol Med, vol.7, pp.1513-1541, 2015. ,
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients, Cell Transplant, vol.16, pp.563-77, 2007. ,
, Commission directive 2003/94/EC, Off J Eur Union, vol.46, pp.262-284, 2003.
Cellular manufacturing for clinical applications, Dev Ophthalmol, vol.53, pp.178-88, 2014. ,
Serum-free cell culture: a unifying approach, Cell, vol.22, pp.649-55, 1980. ,
Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation-a cautionary tale, Atherosclerosis, vol.240, pp.121-125, 2015. ,
Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation, Transplantation, vol.70, pp.1780-1787, 2000. ,
Humanized" stem cell culture techniques: the animal serum controversy, Stem Cells Int, p.504723, 2011. ,
The humane collection of fetal bovine serum and possibilities for serumfree cell and tissue culture, Toxicol In Vitro, vol.18, pp.1-12, 2004. ,
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy, Mol Ther J Am Soc Gene Ther, vol.9, pp.747-56, 2004. ,
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci U S A, vol.99, pp.8932-8939, 2002. ,
Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs, Biotechnol Prog, vol.22, pp.1294-300, 2006. ,
A consensus introduction to serum replacements and serum-free media for cellular therapies, Cytotherapy, vol.19, pp.155-69, 2017. ,
The use of fetal bovine serum: ethical or scientific problem?, Altern Lab Anim, vol.30, pp.219-246, 2002. ,
A novel serum-free medium for the expansion of human mesenchymal stem cells, Stem Cell Res Ther, vol.1, p.8, 2010. ,
Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells, Cytotherapy, vol.12, pp.637-57, 2010. ,
Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells, vol.25, pp.1603-1612, 2007. ,
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow, Stem Cells, vol.27, pp.2331-2372, 2009. ,
Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum, J Bone Joint Surg Br, vol.87, pp.1426-1459, 2005. ,
Human AB serum and thrombinactivated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue, Stem Cells, vol.25, pp.1270-1278, 2007. ,
Effects of different serum conditions on osteogenic differentiation of human adipose stem cells in vitro, Stem Cell Res Ther, vol.4, p.17, 2013. ,
Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells, Stem Cell Res Ther, vol.4, p.27, 2013. ,
In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability, Stem Cells, vol.23, pp.1357-66, 2005. ,
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use, Exp Hematol, vol.32, pp.1212-1237, 2004. ,
Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion, Transfusion, vol.42, pp.921-928, 2002. ,
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate, Cell Prolif, vol.45, pp.66-75, 2012. ,
Making the switch: alternatives to fetal bovine serum for adipose-derived stromal cell expansion, Front Cell Dev Biol, vol.4, p.115, 2016. ,
Culture medium supplements derived from human platelet and plasma: cell commitment and proliferation support, Front Bioeng Biotechnol, vol.5, p.66, 2017. ,
Choice of xenogenicfree expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells, Cytotherapy, vol.18, pp.344-59, 2016. ,
Classification of platelet concentrates (platelet-rich plasma-PRP, plateletrich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives, Muscles Ligaments Tendons J, vol.4, pp.3-9, 2014. ,
The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma, Clin Biochem, vol.42, pp.1452-60, 2009. ,
Growth factor levels in plateletrich plasma and correlations with donor age, sex, and platelet count, J Cranio-Maxillo-Facial Surg, vol.30, pp.97-102, 2002. ,
Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells, Cytotherapy, vol.12, pp.888-98, 2010. ,
Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?, Biomaterials, vol.76, pp.371-87, 2016. ,
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications, J Cell Physiol, vol.205, pp.228-264, 2005. ,
Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells, PLoS One, vol.7, p.37839, 2012. ,
Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion, New Biotechnol, vol.32, pp.199-211, 2015. ,
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute, J Cell Physiol, vol.211, pp.121-151, 2007. ,
Platelet-derived growth factors enhance proliferation of human stromal stem cells, Biomaterials, vol.24, pp.3095-100, 2003. ,
Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components, Cytotherapy, vol.14, pp.540-54, 2012. ,
Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate, Biomaterials, vol.31, pp.270-278, 2010. ,
Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle, Cytotechnology, vol.48, pp.89-95, 2005. ,
Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness, PLoS One, vol.8, p.64923, 2013. ,
Platelet-rich plasma, especially when combined with a TGF-? inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro, PLoS One, vol.10, p.117302, 2015. ,
Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells, Proteomics, vol.16, pp.2028-2070, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01332030
Differential gene expression profiling of dystrophic dog muscle after MuStem cell transplantation, PLoS One, vol.10, p.123336, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01222898
Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs, Am J Pathol, vol.179, pp.2501-2519, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00712818
Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation, BMC Musculoskelet Disord, vol.17, p.209, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01321085
Skeletal muscle regenerative potential of human MuStem cells following transplantation into injured mice muscle, Mol Ther, vol.26, pp.618-633, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01673455
Telomere shortening and tumor formation by mouse cells lacking telomerase RNA, Cell, vol.91, pp.25-34, 1997. ,
Fiji: an open-source platform for biological-image analysis, Nat Methods, vol.9, pp.676-82, 2012. ,
Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency, Cell, vol.162, pp.412-436, 2015. ,
Gene expression omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Res, vol.30, pp.207-217, 2002. ,
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014. ,
Culture and characterization of human bone marrow mesenchymal stem cells, Methods Mol Med, vol.140, pp.67-81, 2007. ,
Telomerase immortalized human amnion-and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics, Tissue Eng Part A, vol.15, pp.1843-54, 2009. ,
Mixed-Effects Models in S and S-PLUS Springer Science & Business Media, 2009. ,
Sample Size Calculations in Clinical Research Chapman & Hall/CRC, Biostatistics Series, 2003. ,
Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells, Blood, vol.111, pp.2631-2636, 2008. ,
Heparin treatment increases thioredoxin interacting protein expression in hepatocellular carcinoma cells, Int J Biochem Cell Biol, vol.65, pp.169-81, 2015. ,
High and low affinity heparin-binding sites in the G domain of the mouse laminin alpha 4 chain, J Biol Chem, vol.275, pp.29458-65, 2000. ,
Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells, PLoS One, vol.12, p.181406, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02620790
A standardized and characterized clinical grade human platelet lysate for efficient expansion of human bone marrow mesenchymal stem cells, ISCT Annu Meet Cytotherapy, vol.195, issue.5, p.279, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02624673
The use of platelet-rich and platelet-poor plasma to enhance differentiation of skeletal myoblasts, Am J Sports Med, p.363546516677547, 2016. ,
Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation, Mol Cell Biol, vol.33, pp.678-87, 2013. ,
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells, Leukemia, vol.29, pp.1839-1885, 2015. ,
Standardized and clinical grade human platelet lysate hydrogel (HPLG) for the optimization of large-scale expansion of human mesenchymal stem cells. 21st ISCT Annu Meet Cytotherapy, vol.17, p.69, 2016. ,
Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures, Cytotherapy, vol.15, pp.1458-68, 2013. ,
Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate, J Transl Med, vol.13, 2015. ,
A standardized and characterized GMP-compliant human platelet lysate for efficient expansion of human bone marrow mesenchymal stem cells. 21st ISCT Annu Meet Cytotherapy, vol.16, p.131, 2016. ,
Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor, J Biol Chem, vol.265, pp.5960-5963, 1990. ,
Type beta transforming growth factor is an inhibitor of myogenic differentiation, Proc Natl Acad Sci U S A, vol.83, pp.8206-8216, 1986. ,